Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Chinook Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +4 vs. Q4 2022
- Shares held
- 61.5M
- +2.78M (+4.7%) vs. Q4 2022
- Total value
- $1.42B
- −$98.0M (−6.4%) vs. Q4 2022
- New holders
- 20
- 57 more added
- Sold out
- 16
- 49 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119.5M | 24.70% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100.6M | 7.28% | 00.0% | Unchanged |
| BlackRock Inc. | 3,942,539 | $91.3M | 0.00% | −12,202−0.3% | Reduced |
| Deep Track Capital, LP | 3,000,000 | $69.5M | 2.95% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,847,835 | $65.9M | 0.00% | +55,261+2.0% | Added |
| State Street Corp | 2,688,048 | $62.2M | 0.00% | +29,092+1.1% | Added |
| Octagon Capital Advisors LP | 2,551,703 | $59.1M | 8.52% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,029,300 | $47.0M | 0.93% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,704,000 | $39.4M | 0.09% | +883,822+107.8% | Added |
| Suvretta Capital Management, LLC | 1,568,797 | $36.3M | 1.75% | +123,967+8.6% | Added |
| Baker Bros. Advisors LP | 1,455,202 | $33.7M | 0.18% | −1,078,900−42.6% | Reduced |
| Eventide Asset Management, LLC | 1,439,564 | $33.3M | 0.61% | +1,070,753+290.3% | Added |
| Assenagon Asset Management S.A. | 1,371,469 | $31.7M | 0.13% | +483,220+54.4% | Added |
| Franklin Resources Inc | 1,312,158 | $30.4M | 0.02% | +1,312,158 | New |
| Dimensional Fund Advisors LP | 1,284,521 | $29.7M | 0.01% | +46,441+3.8% | Added |
| Federated Hermes, Inc. | 1,252,388 | $29.0M | 0.07% | +363,934+41.0% | Added |
| Pictet Asset Management SA | 1,174,756 | $27.2M | 0.03% | +8,592+0.7% | Added |
| Sofinnova Investments, Inc. | 1,002,348 | $23.2M | 1.57% | +195,889+24.3% | Added |
| Victory Capital Management Inc | 991,014 | $22.9M | 0.03% | −172,231−14.8% | Reduced |
| Affinity Asset Advisors, LLC | 976,021 | $22.6M | 8.68% | +157,986+19.3% | Added |
| Nicholas Investment Partners, LP | 972,191 | $22.5M | 1.71% | +329,471+51.3% | Added |
| Geode Capital Management, LLC | 948,551 | $22.0M | 0.00% | +34,325+3.8% | Added |
| Vivo Capital, LLC | 872,151 | $20.2M | 1.51% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 926,155 | $19.7M | 0.14% | 00.0% | Unchanged |
| Laurion Capital Management LP | 829,750 | $19.2M | 0.87% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 755,336 | $17.5M | 0.25% | −17,364−2.2% | Reduced |
| Nuveen Asset Management, LLC | 746,172 | $17.3M | 0.01% | −170,593−18.6% | Reduced |
| Point72 Asset Management, L.P. | 732,169 | $16.9M | 0.06% | −535,491−42.2% | Reduced |
| Rubric Capital Management LP | 719,809 | $16.7M | 0.66% | 00.0% | Unchanged |
| Northern Trust Corp | 533,104 | $12.3M | 0.00% | −708−0.1% | Reduced |
| Rock Springs Capital Management LP | 507,512 | $11.7M | 0.28% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 506,818 | $11.7M | 8.76% | +83,641+19.8% | Added |
| Baillie Gifford & Co | 486,595 | $11.3M | 0.01% | −3,113−0.6% | Reduced |
| EcoR1 Capital, LLC | 445,550 | $10.3M | 0.33% | −244,450−35.4% | Reduced |
| Walleye Capital LLC | 394,100 | $9.12M | 0.18% | +262,725+200.0% | Added |
| Charles Schwab Investment Management Inc | 378,127 | $8.75M | 0.00% | −5,585−1.5% | Reduced |
| Ensign Peak Advisors, Inc | 361,838 | $8.38M | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 349,306 | $8.09M | 0.00% | +137,130+64.6% | Added |
| International Biotechnology Trust PLC | 319,989 | $7.41M | 2.07% | −20,400−6.0% | Reduced |
| D. E. Shaw & Co., Inc. | 319,706 | $7.40M | 0.01% | −40,079−11.1% | Reduced |
| Bank of America Corp | 314,675 | $7.28M | 0.00% | +139,652+79.8% | Added |
| Erste Asset Management GmbH | 307,769 | $7.12M | 0.14% | 00.0% | Unchanged |
| Altium Capital Management LP | 305,000 | $7.06M | 4.22% | −80,000−20.8% | Reduced |
| Ikarian Capital, LLC | 283,464 | $6.56M | 2.72% | 00.0% | Unchanged |
| FMR LLC | 264,760 | $6.13M | 0.00% | −42,050−13.7% | Reduced |
| Artal Group S.A. | 258,687 | $5.99M | 0.36% | +258,687 | New |
| Morgan Stanley | 251,840 | $5.83M | 0.00% | −30,171−10.7% | Reduced |
| Millennium Management LLC | 248,454 | $5.75M | 0.01% | −192,284−43.6% | Reduced |
| Two Sigma Advisers, LP | 214,880 | $4.97M | 0.01% | −22,100−9.3% | Reduced |
| MPM Oncology Impact Management LP | 197,806 | $4.58M | 1.19% | +117,806+147.3% | Added |
| Bank of New York Mellon Corp | 195,352 | $4.52M | 0.00% | −25,707−11.6% | Reduced |
| Rafferty Asset Management, LLC | 181,074 | $4.19M | 0.03% | +7,063+4.1% | Added |
| Putnam Investments LLC | 180,343 | $4.17M | 0.01% | −3,000−1.6% | Reduced |
| Polar Capital Holdings Plc | 175,000 | $4.05M | 0.03% | +175,000 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 170,211 | $3.94M | 0.02% | −65,605−27.8% | Reduced |
| JPMorgan Chase & Co | 157,964 | $3.66M | 0.00% | +5,979+3.9% | Added |
| Two Sigma Investments, LP | 154,265 | $3.57M | 0.01% | +15,637+11.3% | Added |
| SG Americas Securities, LLC | 153,882 | $3.56M | 0.05% | +145,861+1,818.5% | Added |
| Integral Health Asset Management, LLC | 152,000 | $3.52M | 0.73% | −23,000−13.1% | Reduced |
| Polar Asset Management Partners Inc. | 149,600 | $3.46M | 0.06% | 00.0% | Unchanged |
| Citigroup Inc | 147,810 | $3.42M | 0.00% | +69,615+89.0% | Added |
| Algert Global LLC | 136,316 | $3.16M | 0.15% | +4,889+3.7% | Added |
| CHI Advisors LLC | 135,000 | $3.13M | 0.83% | +135,000 | New |
| Renaissance Technologies LLC | 116,562 | $2.70M | 0.00% | −65,100−35.8% | Reduced |
| Nan Fung Group Holdings Ltd | 113,950 | $2.64M | 1.80% | 00.0% | Unchanged |
| Citadel Advisors LLC | 112,181 | $2.60M | 0.00% | −398,986−78.1% | Reduced |
| Sphera Funds Management Ltd. | 92,200 | $2.13M | 0.46% | −35,000−27.5% | Reduced |
| Swiss National Bank | 89,700 | $2.08M | 0.00% | −9,000−9.1% | Reduced |
| Barclays PLC | 83,925 | $1.94M | 0.00% | −18,016−17.7% | Reduced |
| Tekla Capital Management LLC | 83,500 | $1.93M | 0.07% | +83,500 | New |
| Rhumbline Advisers | 81,771 | $1.89M | 0.00% | +678+0.8% | Added |
| Susquehanna International Group, LLP | 78,715 | $1.82M | 0.00% | +51,432+188.5% | Added |
| UBS Group AG | 76,988 | $1.78M | 0.00% | +8,224+12.0% | Added |
| Hudson Bay Capital Management LP | 61,611 | $1.43M | 0.02% | +61,611 | New |
| New York State Common Retirement Fund | 58,421 | $1.35M | 0.00% | −11,695−16.7% | Reduced |
| Wellington Management Group LLP | 56,703 | $1.31M | 0.00% | −890−1.5% | Reduced |
| California State Teachers Retirement System | 55,359 | $1.28M | 0.00% | −452−0.8% | Reduced |
| Weiss Multi-Strategy Advisers LLC | 54,054 | $1.25M | 0.03% | +44,054+440.5% | Added |
| Deutsche Bank AG | 53,840 | $1.25M | 0.00% | +31,610+142.2% | Added |
| Alliancebernstein L.P. | 52,520 | $1.22M | 0.00% | 00.0% | Unchanged |
| HighVista Strategies LLC | 49,495 | $1.15M | 0.93% | 00.0% | Unchanged |
| EAM Investors, LLC | 48,875 | $1.13M | 0.22% | −53,132−52.1% | Reduced |
| Martingale Asset Management L P | 45,538 | $1.05M | 0.02% | +50.0% | Added |
| Alps Advisors Inc | 43,380 | $1.00M | 0.01% | +39+0.1% | Added |
| Wells Fargo & Company | 40,241 | $931.6K | 0.00% | +39,174+3,671.4% | Added |
| Invesco Ltd. | 37,738 | $873.6K | 0.00% | −170,794−81.9% | Reduced |
| State of Wisconsin Investment Board | 36,938 | $855.1K | 0.00% | −4,060−9.9% | Reduced |
| Hennion & Walsh Asset Management, Inc. | 36,946 | $855.0K | 0.05% | +10,574+40.1% | Added |
| Jane Street Group, LLC | 35,949 | $832.2K | 0.00% | +35,949 | New |
| Fisher Asset Management, LLC | 35,903 | $831.2K | 0.00% | −8,100−18.4% | Reduced |
| Credit Suisse AG | 34,251 | $792.9K | 0.00% | +2,074+6.4% | Added |
| Profund Advisors LLC | 33,924 | $785.3K | 0.05% | +33,924 | New |
| Mirae Asset Global Investments Co., Ltd. | 31,285 | $724.2K | 0.00% | +6,872+28.1% | Added |
| ClariVest Asset Management LLC | 31,060 | $719.0K | 0.03% | −124−0.4% | Reduced |
| Advisory Research Inc | 30,927 | $716.0K | 0.12% | −174−0.6% | Reduced |
| Price T Rowe Associates Inc | 28,322 | $657.0K | 0.00% | +861+3.1% | Added |
| Ziegler Capital Management, LLC | 26,725 | $618.7K | 0.02% | +259+1.0% | Added |
| MetLife Investment Management | 26,495 | $613.4K | 0.00% | 00.0% | Unchanged |
| Legato Capital Management LLC | 26,444 | $612.2K | 0.11% | 00.0% | Unchanged |
| Panagora Asset Management Inc | 25,220 | $583.8K | 0.00% | 00.0% | Unchanged |